These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6115223)

  • 1. Is prostacyclin better than nothing for anticoagulation in haemodialysis?
    Abuelo JG; Chang BS
    Lancet; 1981 Aug; 2(8244):470-1. PubMed ID: 6115223
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin safer than heparin in haemodialysis.
    Arze RS; Ward MK
    Lancet; 1981 Jul; 2(8236):50. PubMed ID: 6113427
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation during haemodialysis in patients at high-risk of bleeding.
    Kim YG
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S23-7. PubMed ID: 15012687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis.
    Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH
    Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
    Gainza FJ; Quintanilla N; Pijoan JI; Delgado S; Urbizu JM; Lampreabe I
    J Nephrol; 2006; 19(5):648-55. PubMed ID: 17136695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
    Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
    N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation with prostaglandins during extracorporeal circulation.
    Kozek-Langenecker SA
    Wien Klin Wochenschr; 1999 Feb; 111(4):129-40. PubMed ID: 10192145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute renal failure - anticoagulation in continuous renal replacement therapy].
    Hein OV; Birnbaum J; Spies C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):294-301; quiz 302. PubMed ID: 18409124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodialysis without heparin.
    Woods HF; Weston MJ; Bunting S
    Proc Eur Dial Transplant Assoc; 1978; 15():122-9. PubMed ID: 368769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
    Skagerlind MSE; Stegmayr BG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodialysis with prostacyclin (Epoprostenol) alone.
    Rylance PB; Gordge MP; Ireland H; Lane DA; Weston MJ
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():281-6. PubMed ID: 3887374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.
    Davenport A; Will EJ; Davison AM
    Nephron; 1994; 66(4):431-7. PubMed ID: 8015647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing hemorrhagic complications in dialysis patients.
    Lohr JW; Schwab SJ
    J Am Soc Nephrol; 1991 Nov; 2(5):961-75. PubMed ID: 1760540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Lancet; 1980 Aug; 2(8188):219-22. PubMed ID: 6105392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin can replace heparin in haemodialysis in dogs.
    Woods HF; Ash G; Weston MJ; Bunting S; Moncada S; Vane JR
    Lancet; 1978 Nov; 2(8099):1075-7. PubMed ID: 82090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.
    Pinnick RV; Wiegmann TB; Diederich DA
    N Engl J Med; 1983 Feb; 308(5):258-61. PubMed ID: 6848936
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
    Româo JE; Fadil MA; Sabbaga E; Marcondes M
    Nephrol Dial Transplant; 1997 Jan; 12(1):106-10. PubMed ID: 9027783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of prostacyclin and heparin on hemodialyses in dogs.
    Gross M; Bush H; McTigue H; Hamburger RJ; Flamenbaum W
    Prostaglandins; 1981 Jun; 21(6):879-88. PubMed ID: 7027320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.